|
|
| | ledipasvir interMediate Basic information |
| Product Name: | ledipasvir interMediate | | Synonyms: | 2-Azabicyclo[2.2.1]heptane-2-carboxylic acid, 3-[6-[9,9-difluoro-7-[2-[(6S)-5-[(2S)-2-[(Methoxycarbonyl)aMino]-3-Methyl-1-oxobutyl]-5-azaspiro[2.4]hept-6-yl]-1H-iMidazol-5-yl]-9H-fluoren-2-yl]-1H-benziMidazol-2-yl]-, 1,1-diMethylethyl ester, (1R,3S,4S)-;(1R,3S,4S)-3-[6-[9,9-Difluoro-7-[2-[(6S)-5-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-azaspiro[2.4]hept-6-yl]-1H-imidazol-5-yl]-9H-fluoren-2-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-dimethylethyl ester | | CAS: | 1256393-27-7 | | MF: | C47H51F2N7O5 | | MW: | 831.95 | | EINECS: | | | Product Categories: | | | Mol File: | 1256393-27-7.mol |  |
| | ledipasvir interMediate Chemical Properties |
| density | 1.41±0.1 g/cm3(Predicted) | | pka | 11.20±0.10(Predicted) |
| | ledipasvir interMediate Usage And Synthesis |
| | ledipasvir interMediate Preparation Products And Raw materials |
|